Loading organizations...
§ Private Profile · Tarboro, NC, USA
Drug discovery company developing monoclonal antibody treatments.
Vascular Pharmaceuticals has raised $25.0M across 2 funding rounds.
Vascular Pharmaceuticals has raised $25.0M in total across 2 funding rounds.
Vascular Pharmaceuticals has raised $25.0M in total across 2 funding rounds.
Vascular Pharmaceuticals's investors include Benjamin Rovinski, Ph.D., Intersouth Partners, MPM Capital, Richard Kent, Vaughn Kailian.
Vascular Pharmaceuticals has raised $25.0M across 2 funding rounds. Most recently, it raised $9.0M Series A Extension in March 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 3, 2015 | $9M Series A Plus | Benjamin Rovinski, Ph.d. | Intersouth Partners, MPM Capital | Announced |
| Sep 12, 2012 | $16M Series A | Richard Kent, Vaughn Kailian | — | Announced |